Carbohydrates and fiber linked to healthier aging in some groups, study finds
Carbohydrates may have gotten a bad rap, but a new study from Tufts University finds that some are better than others — and that older women in particular could reap the benefits.
The research, which was recently published in the journal JAMA Network Open, found that daily consumption of fiber and "high-quality" carbs in midlife can contribute to healthier aging and overall better wellness among older females.
The researchers defined "healthy aging" as "the absence of 11 major chronic diseases, lack of cognitive and physical function impairments, and having good mental health."
Experts Reveal Hidden Ways Sugar Accelerates Aging Beyond Just Weight Gain
The study was led by researchers from the Jean Mayer USDA Human Nutrition Research Center on Aging (HNRCA) at Tufts University and Harvard T.H. Chan School of Public Health.
"The main takeaway of the study is that consuming dietary fiber and high-quality carbohydrates — those from fruits, vegetables, whole grains and legumes — is associated with positive health status in older adulthood," lead author Andres Ardisson Korat, a scientist at HNRCA, told Fox News Digital.
Read On The Fox News App
"This includes the absence of chronic diseases and good physical and cognitive function."
The researchers collected data from the Nurses' Health Study, in which 47,000 women reported their dietary habits and health outcomes between 1984 and 2016, according to a Tufts press release.
The women ranged in age from 70 to 93 by the end of the study period.
Eating This Breakfast Food Could Help You Live Longer, Study Suggests
The researchers looked at the women's consumption of dietary fiber, total carbohydrates, refined carbohydrates, high-quality (unrefined) carbohydrates, and carbohydrates from whole grains, fruits, vegetables and legumes.
They also analyzed glycemic index (each food's score indicating how much it raises blood sugar) and glycemic load, which also takes into account portion size to provide a more accurate measure of each food's impact on blood sugar.
Women who consumed higher amounts of total carbohydrates; high-quality carbohydrates from whole grains, fruits, vegetables and legumes; and total dietary fiber in midlife were 6% to 37% more likely to have healthy aging and to score higher in several areas of mental and physical wellness, the study found.
Conversely, consuming refined carbohydrates — which come from added sugars, refined grains and potatoes — and starchy vegetables resulted in a 13% reduced chance of healthy aging.
"This study reinforces something many of us intuitively feel: quality matters," noted Melanie Avalon, a health influencer, entrepreneur and biohacker based in Atlanta, Georgia.
"It's not just about 'carbs versus fats versus protein' — it's about the kind of carbs you're eating."
Avalon, who was not involved in the research, discussed some of the more notable findings with Fox News Digital.
"Perhaps most surprising was the finding that replacing just 5% of calories from carbohydrates with protein (from either plant or animal sources) was associated with lower odds of healthy aging by 7% to 37%," she said.
Healthy Eating In Middle Age Has This Key Longevity Benefit
Avalon also noted that when carbohydrates were segmented by type — processed versus unprocessed — the associations with healthy aging were independent of BMI (body mass index), a metric typically closely linked to metabolic health.
"This suggests the effects of carbohydrate quality on healthy aging were not solely explained by weight-loss effects," she said.
The study also briefly touched on the controversial topic of seed oils.
"It found that higher intake of polyunsaturated fatty acids (PUFAs) — which are commonly found in seed oils — was linked to decreased odds of healthy aging, adding nuance to the ongoing debate," Avalon added.
Based on the study findings, the biohacker recommends favoring whole, unprocessed foods, including fruits, vegetables, legumes and whole grains.
"Shop the perimeter of the grocery store for produce and whole grains, as well as the freezer aisles for frozen fruit and vegetables," she suggested. "Consider dipping into the aisles only for pantry staples like canned legumes."
For those who tolerate grains, people can reap the benefits of foods like quinoa, brown rice, oats and whole wheat products, Avalon noted.
"Prioritize fiber-rich foods and minimize refined carbohydrates like white bread, sugary beverages and ultraprocessed snacks."
"These shifts can meaningfully support healthy aging and reduce the risk of chronic disease."
One chief limitation of the study is that the participants were mainly white female healthcare workers.
"Because of the observational nature of the study, we cannot rule out confounding by other variables," Korat said. "We would have liked to have data on men to evaluate the associations in this group."
Click Here To Sign Up For Our Health Newsletter
The researchers called for more diverse studies that look closer at how dietary fiber and high-quality carbs contribute to healthy aging.
"We hope our findings help inform consumers about the importance of healthy diets in the promotion of healthy aging," Korat added.
"The more we can understand about healthy aging, the more science can help people live healthier for longer."
Avalon added that while diet is "foundational," it's just one piece of the "healthy aging puzzle."
For more Health articles, visit www.foxnews.com/health
"Exercise, sleep, stress management and social connection all play a role," she said.
"Ultimately, personalized nutrition, grounded in both science and self-awareness, may be key to thriving across the decades."Original article source: Carbohydrates and fiber linked to healthier aging in some groups, study finds
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
15 minutes ago
- Yahoo
Common menopause medication might prevent breast cancer while treating hot flashes
A drug intended to treat menopause symptoms could double as breast cancer prevention. New research from Northwestern University in Illinois found that Duavee, a Pfizer-made drug, "significantly reduced" breast tissue cell growth, which is a major indicator of cancer progression. A phase 2 clinical trial included 141 post-menopausal women who had been diagnosed with ductal carcinoma in situ (DCIS), also known as stage 0 breast cancer, according to a press release from Northwestern. Prostate Cancer Drug Now Available To More Patients With Aggressive Form Of Disease This non-invasive breast cancer affects more than 60,000 American women each year, often leading to an outcome of invasive breast cancer. The women were separated into two groups — one received Duavee and the other took a placebo for a month before undergoing breast surgery. Read On The Fox News App Duavee is a conjugated estrogen/bazedoxifene (CE/BZA) drug, which combines estrogen with another medication that minimizes the potential harmful side effects of the hormone. "The key takeaway from the study is that CE/BZA slows the growth (proliferation) of cells in milk ducts of DCIS that expressed the estrogen receptor significantly more than placebo," Dr. Swati Kulkarni, lead investigator and professor of breast surgery at Northwestern University Feinberg School of Medicine, told Fox News Digital. Experimental Women's Cancer Drug Boosts Survival Rates In Notable Study Another major finding is that the quality of life did not differ significantly between the two groups, but patients who took the CE/BZA reported fewer hot flashes during the study, she noted. "This would be expected, as the drug is FDA-approved to treat hot flashes." Kulkarni presented the study last week at the American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago. The findings are preliminary and have not yet been published in a medical journal. "What excites me most is that a medication designed to help women feel better during menopause may also reduce their risk of invasive breast cancer," said the doctor, who is also a Northwestern Medicine breast surgeon. Women who face a higher risk of breast cancer — including those who have experienced "high-risk lesions" — and who also have menopausal symptoms are most likely to benefit from the drug, according to Kulkarni. "These women are typically advised against standard hormone therapies, leaving them with few menopausal treatment options," the release stated. The researchers said they are "encouraged" by these early results, but more research is required before the medication can be considered for approval as a breast cancer prevention mechanism. "Our findings suggest that CE/BZA may prevent breast cancer, but larger studies with several years of follow-up are needed before we would know this for sure," Kulkarni told Fox News Digital. Dr. Sheheryar Kabraji, chief of breast medicine at the Roswell Park Comprehensive Cancer Center in Buffalo, New York, was not involved in the study but commented on the findings. "While intriguing, this study is highly preliminary, and more research will be needed before we can conclude that conjugated estrogen/bazedoxifene (CD/BZA), a form of the hormone estrogen commonly prescribed to address symptoms of menopause, prevents invasive breast cancer or is effective at reducing cancer risk," she told Fox News Digital. Click Here To Sign Up For Our Health Newsletter Kabraji also noted that the study focused on reducing levels of one specific protein, "which does not always predict reduced recurrence of breast cancer." "This study did not directly show that CE/BZA treatment reduces the risk of DCIS recurrence or development of invasive cancer," she noted. "Importantly, however, patients who received this therapy experienced no worsening of quality of life, and saw improvement in vasomotor symptoms, such as hot flashes. If found to be effective in preventing breast cancer, CE/BZA is likely to have fewer side effects than current medications used for breast cancer prevention." For more Health articles, visit Lead researcher Kulkarni emphasized that this medication is not for the treatment of invasive breast cancer or DCIS. "Right now, we can say that women who are concerned about their risk of developing breast cancer can consider this medication to treat their menopausal symptoms," she article source: Common menopause medication might prevent breast cancer while treating hot flashes
Yahoo
17 hours ago
- Yahoo
UnitedHealthcare sues The Guardian for defamation after explosive nursing home story
UnitedHealthcare is suing British newspaper The Guardian for defamation, alleging that the outlet falsely accused them of enticing nursing homes to enroll in a special program that works to restrict medical expenses for elderly patients. "The Guardian knowingly published false and misleading claims about our Institutional Special Needs Program, forcing us to take action to protect the clinician-patient relationship that is crucial for delivering high-quality care. The Guardian refused to engage with the truth and chose instead to print its predetermined narrative," UnitedHealthcare told Fox News Digital in a statement. The Guardian article, published May 21, claimed that UnitedHealthcare is pursuing cost-cutting tactics that jeopardize the health of nursing home patients. The article claims that the health insurance giant provides what amounts to secret bonuses to enroll in a program that stations medical staff that reports directly to UnitedHealthcare, and in practice works to reduce hospitalizations for patients, some of whom allegedly may urgently need the care. Unitedhealthcare Ceo Murder Suspect Luigi Mangione Indicted In New York The article also claims UnitedHealthcare financially entices nursing homes to join their "Institutional Special Needs" program, and allegedly illegally had nursing homes share confidential patient data with the insurer so that it could skirt federal law and market programs to patients – some of whom lack the capacity to make financial decisions on their own – and families. The Guardian also alleged that UnitedHealthcare leaned on nursing home staff to convince patients to sign DNR's, even if they had expressed a desire for all medical options to be used to save their life. "A recent article published by The Guardian presents a narrative built largely on anecdotes rather than facts. It is unfortunate that the article misrepresents a program that, in reality, improves health outcomes for seniors through on-site clinical care, personalized treatment plans, and enhanced coordination among caregivers. We stand firmly behind the integrity of our programs, which consistently receive high satisfaction ratings from our members," UnitedHealthcare said in a statement in response to the article in May. Read On The Fox News App The lawsuit alleged that The Guardian used a "heavily cropped screenshot" of an internal UnitedHealthcare email which they claim, when seen in full, contradicts their reporting. The suit also accuses The Guardian of "gratuitously" linking its report to the assassination of their former CEO Brian Thompson. Unitedhealth Shares Slide As Criminal Probe Report Adds To Investor Fears "The Guardian knew these accusations were false, but published them anyway," the lawsuit stated. The Guardian told Fox News Digital it stood by its reporting. "The Guardian stands by its deeply-sourced, independent reporting, which is based on thousands of corporate and patient records, publicly filed lawsuits, declarations submitted to federal and state agencies, and interviews with more than 20 current and former UnitedHealth employees – as well as statements and information provided by UnitedHealth itself over several weeks. It's outrageous that in response to factual reporting on the practice of secretly paying nursing homes to reduce hospitalizations for vulnerable patients, UnitedHealth is resorting to wildly misleading claims and intimidation tactics via the courts," a representative from The Guardian said. Click To Get The Fox News App When asked by Fox News Digital for clarification regarding the "heavily cropped screenshot," a representative for The Guardian said the image was in fact a "visual illustration" and the so-called missing information was provided "in an on-record comment and a denial from UnitedHealth" in the proceeding paragraph. The Guardian rep also claimed that UnitedHealthcare never asked the press outlet to alter the article source: UnitedHealthcare sues The Guardian for defamation after explosive nursing home story


Fox News
a day ago
- Fox News
Chinese bioweapon smuggling case shows US 'trains our enemies,' 'learned nothing' from COVID: security expert
In response to the Department of Justice charging two Chinese nationals – including a University of Michigan research fellow – with allegedly smuggling a potential "agroterrorism" weapon into the U.S., national security experts tell Fox News Digital that the Trump administration must continue to take action to prevent American colleges and companies from "essentially educating and arming our chief adversary in the world." "In some cases, it seems like we learned nothing from COVID," Christian Whiton, a former senior foreign policy advisor in the Bush and Trump administrations, told Fox News Digital. "We allow direct flights now from China to the U.S. mainland. Again, that is crazy. And the whole fact that we are allowing researchers, even in the realm of dealing with pathogens to have access anywhere in the United States, much less the universities, is pretty insane. It seems like a pre-COVID mindset." The two Chinese nationals were charged Tuesday with smuggling Fusarium graminearum fungus, a dangerous biological pathogen and "known agroterrorism agent" responsible for billions of dollars in economic losses worldwide each year, through Detroit's airport. The noxious substance causes "head blight," a disease of wheat, barley, maize, and rice, according to federal prosecutors. In humans and livestock, exposure to its toxins causes vomiting, liver damage, and reproductive defects. "It's a new take on Chinese espionage and sabotage of the US economy. But it's not a surprise. I think that China has failed to pull back on any of its aggressive activity. And this is something that the Trump administration probably wants to take into consideration," Whiton said of the case. "I think it's both the government and our universities have let down the American people." Whiton told Fox News Digital that Chinese infiltration of U.S. institutions has been happening since at least the 1990s – when Chinese spies stole American nuclear secrets from Los Alamos National Laboratory in New Mexico – and since then, "there's been this systemic desire to put Chinese nationals into especially these technical areas, technical universities." Whiton said Beijing does not consider only Chinese citizens as its agents, as "anyone of Chinese ethnicity" have been viewed as "fair game" to be recruited. He categorized the H1-B visa program as essentially a "scam," asserting that about a quarter are awarded to Chinese nationals who "end up at some of our high-tech companies." Traditionally, Whiton explained, Republicans have believed universities should run themselves without political interference, but doing so has allowed such institutions to be taken over by left-wingers. "Taxpayers are funding these things and shouldn't be forced to fund things that are anathema to their beliefs and what they know to be true. Things like we shouldn't train our enemies at taxpayer expense," Whiton said. "So, I think it goes along with Republicans being pretty wimpy in the past, but only more recently with the emergence of the new right and the MAGA movement finally taking a tougher stand on some of these left-wing universities." Treasury Secretary Scott Bessent has said the United States does not want to de-couple with China, though Beijing has a choice whether to be a reliable partner. "The reality is China is kind of doing what it has always done," Whiton said. "So if we're looking for a change of Chinese conduct because of President Trump being in office, it just hasn't happened yet. So I can't say that's a surprise." Last week, Secretary of State Marco Rubio announced that the Trump administration would "aggressively" revoke the student visas for Chinese nationals, "including those with connections to the Chinese Communist Party or studying in critical fields." After a call with Chinese President Xi Jinping, which the White House said focused mostly on trade, President Donald Trump told reporters in the Oval Office on Thursday that Chinese students were still coming and the U.S. would be "honored" to have them. Yet, the president said the students need to be properly "checked" and the administration wants lists of Chinese nationals admitted to schools, such as Harvard and Columbia, so that vetting can occur. "That's a step in the right direction," Whiton said. "But in reality, we probably need to recognize these are our chief economic and security adversary in the world and take those visa numbers down closer to zero and start sending these people home." Whiton said there is a "faulty assumption" that Chinese students would come to the United States, learn about American culture and bring an appreciation back home to China. "In reality, they sort of come over here, they're in a bubble, they pick up technical skills, and then they go back to China and put them to use for either the military directly or for corporations that are either utilized by the Chinese military or that are trying to undermine U.S. technology companies," Whiton said. "We really are essentially educating and arming our chief adversary in the world." Former Rep. Michelle Steel, a California Republican who served on the House foreign and intelligence committees, told Fox News Digital that Chinese students educated in the U.S. essentially return home without an appreciation for America. "After they study here, they took all of our brains here, and they took everything back to their country, and they are using to attack United States. And they hate United States after that education. Guess what we are teaching in the universities? Not love United States!" Steel, who was born in Korea and grew up in Japan, told Fox News Digital. "They are studying some very sensitive things in our universities. We really had to vet them well." In her eyes, U.S. universities have prioritized bringing in international students for economic gain. "Because of all the money," she said. "They try to build their endowments, and they want to just show how big their research center is." She cited the case against former Chair of Harvard University's Chemistry and Chemical Biology Department, Dr. Charles Lieber, who was convicted in 2023 of lying to federal authorities about his affiliation with the People's Republic of China's Thousand Talents Program and the Wuhan University of Technology (WUT) in Wuhan, China. Federal prosecutors said Lieber had been paid $1.5 million by the CCP and failed to report additional income of $50,000 payments per month from the WUT. "It's not just at University of Michigan, but it's just everywhere," Steel said. "We cannot bring everybody in to these universities and studying together and helping to build CCP's military. That's just totally no-no, because you know what they're doing in the Pacific areas and African countries and South American countries. And they're just expanding everywhere. And we are the only one [who] can stop [it]. And I think President Trump is doing great job." The former congresswoman pointed to how the House Select Committee on the CCP in 2023 uncovered a $220 million payment made by the Chinese government to the University of California at Berkeley to help build a massive, joint institute in China – funding which UC Berkeley failed to disclose under Section 117 of the Higher Education Act. She has advocated for legislation that would decrease the reporting requirement from $250,000 to $50,000. Steel also noted that Stanford University – located in the heart of Silicon Valley in California – has a relationship with China's Peking University, which in turn has ties to the Chinese military and "goes straight into the nuclear program." The current chair of the House Select Committee on the CCP, Rep. John Moolenaar, R-Mich., penned a letter to Stanford in March over concerns about U.S. universities "admitting large numbers of Chinese nationals into advanced STEM programs, potentially at the expense of qualified Americans."